封面
市場調查報告書
商品編碼
1782975

全球OVD(黏彈劑)市場

Ophthalmic Viscosurgical Devices

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 375 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球 OVD(黏彈劑)市場規模將達到 5.643 億美元

全球黏彈劑(OVD) 市場規模預計在 2024 年為 4.298 億美元,預計到 2030 年將達到 5.643 億美元,在 2024-2030 年分析期內的複合年成長率為 4.6%。分散型黏彈劑(OVD) 是本報告分析的細分市場之一,預計其複合年成長率為 3.6%,到分析期結束時規模將達到 2.938 億美元。黏性黏彈劑(OVD) 細分市場在分析期間內的複合年成長率預計為 6.0%。

美國市場規模估計為 1.171 億美元,中國市場預計複合年成長率為 7.2%

美國OVD(黏彈劑)市場規模預計在2024年達到1.171億美元。預計到2030年,作為世界第二大經濟體的中國市場規模將達到1.096億美元,在分析期間(2024-2030年)的複合年成長率為7.2%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間的複合年成長率分別為2.3%和4.6%。在歐洲,預計德國的複合年成長率為2.9%。

全球OVD(黏彈劑)市場-主要趨勢與促進因素摘要

為什麼黏液手術裝置對於現代眼科手術至關重要?

黏彈劑視窗微球 (OVD) 憑藉其在手術中提供關鍵支撐的能力,已成為眼科手術,尤其是白內障手術的基石。這些凝膠狀物質通常由透明質酸鈉和其他黏彈性化合物組成,對於維持前房穩定性、保護眼內組織以及輔助人工水晶體(IOL) 植入至關重要。白內障手術是全球最常見的手術之一,對可靠、特異性視窗微球 ...此外,對術後療效和患者安全的持續關注,促使外科醫生採用先進的視神經導管 (OVD) 來減少內皮損傷和炎症。因此,這些設備不僅在外科手術中必不可少,而且擴大被納入旨在改善視力和恢復狀況的通訊協定中。

產品創新如何推動 OVD 業績?

黏彈劑(OVD) 的創新正在重塑手術的精確度、安全性和效率。其中最重要的進展之一是雙功能 OVD 的開發,它只需一次使用即可兼具維持空間和保護組織的功效。此類配方簡化了手術流程,減少了多次給藥的需要。製造商也在改進超音波的分子結構,以改善流動動力學、提高透明度並增加其在前房的滯留性。這些改進使得在超音波乳化白內障吸除術和人工水晶體植入術中能夠更好地操控眼部結構,尤其是在小瞳孔和虹膜鬆弛症候群等複雜情況下。此外,預填充式注射器和符合人體工學的輸送系統的引入,改善了手術過程中的操作並最大限度地減少了廢棄物。交聯透明質酸配方的進步有助於延長滯留時間並在壓力下提供更好的黏彈性,滿足現代高速手術技術的需求。生物相容性仍然是重點關注點,創新旨在進一步降低發炎、眼壓升高和術後併發症的風險。此外,生物分解性和藥物釋放型的OVD(光學植入物)的研究正在進行中,這些OVD可能在手術過程中提供機械和藥理學方面的益處。這些技術進步不僅改善了手術效果,也使OVD在競爭激烈的市場中脫穎而出。

哪些最終使用者和區域趨勢決定了需求模式?

OVD(黏彈劑)的需求受到終端使用者偏好和區域醫療保健發展的強烈影響。在外科基礎設施發達、病患期望值高的高所得國家,眼科醫師越來越青睞性能和安全性更高的高階 OVD。在美國、德國和日本等國家,發達的眼科中心和較高的手術量保證了高階 OVD 的穩定消費。相較之下,在印度、巴西和東南亞等新興市場的推動下,受白內障手術量增加、醫療保健可近性改善以及政府防盲舉措的推動,OVD 正在快速普及。這些地區需要經濟高效且可靠的 OVD 來支援大量的眼科保健項目和流動手術營。門診手術中心和獨立眼科診所的興起也擴大了無菌一次性 OVD 的購買基礎,這些 OVD 可以快速更換並降低污染風險。學術機構和外科培訓中心將 OVD 的使用納入標準化外科教育通訊協定,進一步促進了需求。此外,私募股權投資的連鎖眼科診所和專利權視力保健網路的興起,正在推動OVD品牌的集中採購和標準化,從而提升領先製造商的市場認知度。這些趨勢凸顯了各細分市場採購行為正朝向更具策略性和量化的趨勢轉變。

推動OVD(黏彈劑)市場成長的關鍵因素有哪些?

OVD(黏彈劑)市場的成長受到與技術進步、手術量擴大和臨床實踐標準轉變相關的多種因素的推動。其中一個關鍵的成長要素是全球白內障手術的增加,這得益於預期壽命的提高和對早期視力恢復選擇的認知不斷提高。微創和雷射輔助手術的轉變推動了對 OVD 的需求,即使在快速的術中條件下,這種 OVD 也能提供增強的保持力、清晰度和腔體穩定性。最終用戶對一次性、無菌和預填充OVD 的需求也在成長,尤其是在門診和高通量手術中心。雙相和黏度自適應 OVD 等持續的產品創新正在將其臨床效用擴展到更廣泛的手術場景中,從標準晶狀體植入到先進的前後分割。在新興市場,透過公共衛生計劃、非政府主導和移動手術室擴大視力保健的可近性正在推動 OVD 的大規模消費。此外,眼科器械製造商與製藥公司之間的策略聯盟正在增強產品捆綁和一體化手術服務。眼科培訓計畫和基於模擬的教育日益普及,加上從業人員對 OVD 高級應用的熟悉度和信心不斷提升,這些因素共同作用,使黏彈劑成為全球眼科護理領域的重要成長因素。

部分

類型(分散性、黏結性、黏附性)、來源(生物來源、動物、半合成)、用途(白內障手術、角膜移植、青光眼手術、玻璃體視網膜移植)

受訪公司範例

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範,而是建立了一個從世界各地專家收集的內容庫,包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口(成品和原始設備製造商)情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手,包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP32432

Global Ophthalmic Viscosurgical Devices Market to Reach US$564.3 Million by 2030

The global market for Ophthalmic Viscosurgical Devices estimated at US$429.8 Million in the year 2024, is expected to reach US$564.3 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Dispersive Ophthalmic Viscosurgical Devices, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$293.8 Million by the end of the analysis period. Growth in the Cohesive Ophthalmic Viscosurgical Devices segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$117.1 Million While China is Forecast to Grow at 7.2% CAGR

The Ophthalmic Viscosurgical Devices market in the U.S. is estimated at US$117.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$109.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Ophthalmic Viscosurgical Devices Market - Key Trends & Drivers Summarized

Why Are Viscosurgical Devices Indispensable in Modern Ocular Surgery?

Ophthalmic Viscosurgical Devices (OVDs) have established themselves as a cornerstone in ocular surgeries, particularly cataract procedures, by offering critical intraoperative support. These gel-like substances, typically composed of sodium hyaluronate or other viscoelastic compounds, are essential in maintaining anterior chamber stability, protecting intraocular tissues, and facilitating intraocular lens (IOL) implantation. With cataract surgery being one of the most frequently performed procedures worldwide, the demand for reliable and high-performing OVDs continues to grow in parallel. Their role is even more vital in complex surgeries such as glaucoma filtering procedures, corneal transplants, and vitreoretinal interventions, where tissue protection and space maintenance are critical. As surgical techniques evolve toward micro-incisional and femtosecond laser-assisted procedures, the reliance on high-purity, phase-specific OVDs is increasing. This trend is reinforced by the rising geriatric population globally, which presents a larger pool of patients requiring age-related eye care interventions. Moreover, the consistent emphasis on post-operative outcomes and patient safety is pushing surgeons to adopt advanced OVDs that reduce endothelial damage and inflammation. Thus, these devices are not only essential from a surgical standpoint but are also becoming increasingly integrated into protocols focused on improving visual outcomes and recovery profiles.

How Is Product Innovation Elevating the Performance of OVDs?

Innovation in ophthalmic viscosurgical devices is reshaping surgical precision, safety, and efficiency. One of the most significant advancements is the development of dual-function OVDs-also known as dispersive-cohesive combinations-which offer the benefits of both space maintenance and tissue protection in a single application. These formulations simplify the surgical process and reduce the need for multiple product administrations. Manufacturers are also refining the molecular structure of viscoelastics to improve flow dynamics, increase transparency, and enhance retention within the anterior chamber. These improvements allow for better manipulation of ocular structures during phacoemulsification and IOL placement, particularly in complex cases such as small pupil or floppy iris syndrome. Additionally, pre-filled syringes and ergonomic delivery systems are being introduced to improve handling and minimize waste during procedures. Advances in cross-linked hyaluronic acid formulations are contributing to prolonged retention and better viscoelastic behavior under stress, aligning with the needs of modern, high-speed surgical techniques. Biocompatibility remains a major focus area, with innovations aiming to further reduce the risk of inflammation, IOP spikes, and post-op complications. Furthermore, research is ongoing into biodegradable and drug-eluting OVDs that could provide both mechanical and pharmacological benefits intraoperatively. These technological strides are not only boosting surgical outcomes but are also creating differentiation in a competitive market landscape.

What End-Use and Geographic Trends Are Defining Demand Patterns?

Demand for ophthalmic viscosurgical devices is being strongly influenced by both end-user preferences and regional healthcare developments. In high-income countries, where surgical infrastructure is advanced and patient expectations are high, ophthalmic surgeons increasingly prefer premium OVDs that offer enhanced performance and safety. The presence of well-established ophthalmology centers and high surgical throughput in countries like the U.S., Germany, and Japan ensures steady consumption of high-grade, branded OVDs. In contrast, emerging markets such as India, Brazil, and parts of Southeast Asia are witnessing rapid adoption driven by rising cataract surgery volumes, improved healthcare access, and government-backed blindness prevention initiatives. In these regions, cost-effective yet reliable OVDs are in demand to support high-volume eye care programs and mobile surgical camps. The increasing number of ambulatory surgical centers and standalone eye clinics is also expanding the buyer base for single-use, pre-sterilized OVDs that enable fast turnover and reduce the risk of contamination. Academic institutions and surgical training centers further contribute to demand as they incorporate OVD use into standardized surgical education protocols. Additionally, the rise of private equity-backed ophthalmology chains and franchised vision care networks is leading to centralized procurement and standardization of OVD brands, increasing market visibility for leading manufacturers. These trends underscore a clear shift toward more strategic and volume-driven purchasing behavior across different market tiers.

What Key Forces Are Fueling Growth in the Ophthalmic Viscosurgical Devices Market?

The growth in the ophthalmic viscosurgical devices market is driven by several factors related to technological refinement, surgical volume expansion, and shifts in clinical practice standards. One of the primary growth drivers is the global increase in cataract surgeries, supported by rising life expectancy and growing awareness of early vision restoration options. The transition toward minimally invasive and laser-assisted surgical techniques is increasing demand for OVDs that offer enhanced retention, clarity, and chamber stability under rapid intraoperative conditions. End-user demand for single-use, sterile, and pre-filled OVD formats is also growing, especially in ambulatory and high-throughput surgical centers. Continued product innovation, including dual-phase and viscoadaptive OVDs, is expanding clinical utility across a broader range of surgical scenarios, from standard lens implantation to advanced anterior and posterior segment procedures. In emerging markets, the expansion of vision care access through public health programs, non-governmental initiatives, and mobile surgical units is driving significant volumes of OVD consumption. Additionally, strategic collaborations between ophthalmic equipment manufacturers and pharmaceutical companies are enhancing product bundling and integrated surgical offerings. The growing penetration of training programs and simulation-based education in ophthalmology is increasing practitioner familiarity and confidence with advanced OVD usage. These combined factors are positioning ophthalmic viscosurgical devices as a critical and growing component within the broader landscape of global eye care.

SCOPE OF STUDY:

The report analyzes the Ophthalmic Viscosurgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices, Viscoadaptive Ophthalmic Viscosurgical Devices); Source (Biological Source, Animal Source, Semi-Synthetic Source); Application (Cataract Surgery Application, Corneal Grafting Application, Glaucoma Surgery Application, Vitreoretinal Grafting Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Ophthalmic Viscosurgical Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cataract Surgery Rates Throw the Spotlight on High-Performance Ophthalmic Viscosurgical Devices (OVDs)
    • Growing Geriatric Population Spur Growth in Age-Related Eye Surgeries and Long-Term Use of Viscosurgical Aids
    • Minimally Invasive Surgical Techniques Expand Addressable Market Opportunity for Low-Viscosity and Dual-Function OVDs
    • Technological Innovations in Rheological Properties Strengthen the Business Case for Advanced Cohesive and Dispersive OVDs
    • Demand for Faster Recovery and Improved Outcomes Drives Adoption of Tissue-Protective, High-Purity OVD Formulations
    • Surge in Refractive and Glaucoma Surgeries Sustains Growth in Multifunctional Viscosurgical Product Portfolios
    • Customized OVD Use in Complex Surgeries Creates Opportunities for Procedure-Specific Product Development
    • Integration of Preloaded, Single-Use Delivery Systems Propels Growth in High-Volume, Ambulatory Surgical Centers
    • Expansion of Ophthalmic Services in Emerging Economies Generates Demand for Cost-Effective, Shelf-Stable OVDs
    • Advancement in Dual-Viscosity and Viscoadaptive Technologies Drive Clinical Efficiency and Reduce Surgical Time
    • Rising Focus on Standardization and Product Training Across Eye Care Chains Spurs Greater OVD Utilization
    • Shift Toward Personalized Eye Surgery Protocols Encourages Development of Indication-Specific Viscosurgical Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ophthalmic Viscosurgical Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vitreoretinal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cataract Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Corneal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Glaucoma Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biological Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Animal Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Semi-Synthetic Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • JAPAN
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CHINA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • EUROPE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • FRANCE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • GERMANY
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • INDIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AFRICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030

IV. COMPETITION